214 related articles for article (PubMed ID: 21813785)
1. AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.
Siritho S; Nakashima I; Takahashi T; Fujihara K; Prayoonwiwat N
Neurology; 2011 Aug; 77(9):827-34. PubMed ID: 21813785
[TBL] [Abstract][Full Text] [Related]
2. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP
Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients.
Kishk NA; Abokrysha NT; Rashed L; Ahmed N
J Clin Neurosci; 2015 Apr; 22(4):670-5. PubMed ID: 25677878
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
Yang Y; Wu WP; Huang DH; Wu L
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.
Yang CS; Zhang DQ; Wang JH; Jin WN; Li MS; Liu J; Zhang CJ; Li T; Shi FD; Yang L
CNS Neurosci Ther; 2014 Jan; 20(1):32-9. PubMed ID: 23890015
[TBL] [Abstract][Full Text] [Related]
6. Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica.
Li W; Minohara M; Piao H; Matsushita T; Masaki K; Matsuoka T; Isobe N; Su JJ; Ohyagi Y; Kira J
Mult Scler; 2009 Dec; 15(12):1411-21. PubMed ID: 19965522
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
8. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions.
Tanaka K; Tani T; Tanaka M; Saida T; Idezuka J; Yamazaki M; Tsujita M; Nakada T; Sakimura K; Nishizawa M
Mult Scler; 2007 Aug; 13(7):850-5. PubMed ID: 17468440
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
[TBL] [Abstract][Full Text] [Related]
10. [Seroprevalence and diagnostic value of aquaporin-4 antibody in patients with inflammatory central nervous system demyelinating diseases].
Wu L; Yang Y; Huang DH; Wu WP
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):350-2. PubMed ID: 21354891
[TBL] [Abstract][Full Text] [Related]
11. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu T; Fujihara K; Itoyama Y
Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
[TBL] [Abstract][Full Text] [Related]
13. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Sato DK; Nakashima I; Takahashi T; Misu T; Waters P; Kuroda H; Nishiyama S; Suzuki C; Takai Y; Fujihara K; Itoyama Y; Aoki M
Neurology; 2013 Jun; 80(24):2210-6. PubMed ID: 23677744
[TBL] [Abstract][Full Text] [Related]
14. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
[TBL] [Abstract][Full Text] [Related]
15. [Anti-aquaporin 4 antibody in Japanese multiple sclerosis with long spinal cord lesions].
Tanaka K
Rinsho Shinkeigaku; 2007 Nov; 47(11):852-4. PubMed ID: 18210816
[TBL] [Abstract][Full Text] [Related]
16. Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania.
Sakalauskaitė-Juodeikienė E; Armalienė G; Kizlaitienė R; Bagdonaitė L; Giedraitienė N; Mickevičienė D; Rastenytė D; Kaubrys G; Jatužis D
Brain Behav; 2018 Nov; 8(11):e01129. PubMed ID: 30284401
[TBL] [Abstract][Full Text] [Related]
17. The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica.
Yang Y; Huang DH; Wu WP; Wu L; Chen LF; Wu Q
J Clin Neurosci; 2013 Jan; 20(1):94-8. PubMed ID: 23142234
[TBL] [Abstract][Full Text] [Related]
18. [What I have learned and accomplished through research on multiple sclerosis (MS)].
Itoyama Y
Rinsho Shinkeigaku; 2009 Nov; 49(11):699-707. PubMed ID: 20030191
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients.
Apiwattanakul M; Asawavichienjinda T; Pulkes T; Tantirittisak T; Hemachudha T; Horta ES; Jenkins SM; Pittock SJ
J Neurol Sci; 2012 Sep; 320(1-2):118-20. PubMed ID: 22831763
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status.
Matsushita T; Isobe N; Piao H; Matsuoka T; Ishizu T; Doi H; Masaki K; Yoshiura T; Yamasaki R; Ohyagi Y; Kira J
J Neurol Sci; 2010 Apr; 291(1-2):37-43. PubMed ID: 20122699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
